Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Launch of new Salagen dosage

March 19, 2004

Crucell and NeoTropiX enter PER.C6 technology licensing agreement

March 18, 2004

AstraZeneca team prepares and tests new Tie-2 inhibitors

March 18, 2004

Argenta describes new HDAC inhibitors and their use in cancer and other disorders

March 18, 2004

New inhibitors of VEGFR2 and FGFR1 identified by BMS scientists

March 18, 2004

Aloxi incorporated in NCCN antiemetic guidelines for CINV

March 18, 2004

TopoTarget and deCODE collaborate on improved cancer treatments

March 18, 2004

Targeting telomerase for multiple myeloma therapy

March 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...